Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Respirics Inc.
DescriptionInhaled dry powder formulation of gentamicin
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationBacterial respiratory infection
Indication DetailsTreat bacterial respiratory infection and TB
Regulatory Designation
PartnerNanotherapeutics Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today